Electromed (ELMD) Gains from Investment Securities (2024 - 2026)
Electromed (ELMD) posted quarterly Gains from Investment Securities of -$94000.0 for Q1 2026, up 72.19% year-over-year from -$54591.1 in Q1 2025, and down 327.27% quarter-over-quarter from -$22000.0 in Q4 2025.
Electromed (ELMD) Gains from Investment Securities (2024 - 2026) Analysis & Trends
Electromed (ELMD) has reported Gains from Investment Securities for 3 consecutive years, with -$94000.0 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Electromed | 329.52 Mn | 312.53 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94,000.00 |
| Mar 31, 2026 | -94,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Sep 30, 2025 | -81,000.00 |
| Sep 30, 2025 | -81,000.00 |
| Mar 31, 2025 | -338,000.00 |
| Mar 31, 2025 | -338,000.00 |
| Dec 31, 2024 | -135,000.00 |
| Dec 31, 2024 | -135,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -99,000.00 |
| Mar 31, 2024 | -99,000.00 |